A new study published in Nature Communications highlights a newly developed contrasting agent for MRI that detects breast cancer in its earliest stages and can distinguish between aggressive and non-aggressive cancers.
Original Article: New MRI contrasting agent detects small, aggressive cancers
NEXT ARTICLE